Skip to main content


Biotech Stock Mailbag: Good Stocks Exist

Find out what stocks escape our biotech expert's wrath.

Biotech Stock Mailbag: HEB's Artful Dodging

Readers chime in on Hemispherx, Genxyme, ASCO, Cell Therapeutics and Cardiome.

Northfield Blood Substitute Rejected by FDA

The Food and Drug Administration refused to approve the human blood substitute, Polyheme, for use in trauma patients suffering from severe blood loss.

Northfield, Polyheme Not Long for This World

An FDA decision to not convene a panel of blood experts to review Northfield Labs' Polyheme is a signal the agency already has decided to reject the blood substitute for approval.

Blood Sub or Not, Northfield's a Negative

With the odds stacked against Polyheme being approved, investors should think hard before chasing this stock.

Breaking News

Micron Stock Tumbles On Grim Chip Sector Outlook After Q3 Earnings Beat

"We saw a significant reduction in near-term industry bit demand, primarily attributable to end demand weakness in consumer markets," said CEO Sanjay Mehrotra.

Tesla Q2 Deliveries In Focus Following Record Quarterly Stock Slump, China Shutdowns

Tesla will publish Q2 deliveries over the coming days following the biggest three-month decline on record for shares of the world's most-valuable carmaker.

Kohl's Stock Plunges As Retailer Scraps Franchise Group Sale Talks

"Given the environment and market volatility, the Board determined that it simply was not prudent to continue pursuing a deal," said chairman Peter Boneparth.

General Motors Stock Halted, Edge Higher After Detailing Q2 Chip Shortage Hit To Inventory

GM said chip shortages and supply chain snarls left nearly 100,000 vehicles unfinished over the second quarter.